Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Expands By 200.0%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBXGet Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 300 shares, an increase of 200.0% from the March 15th total of 100 shares. Based on an average daily volume of 56,600 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Price Performance

CNBX remained flat at $0.01 during trading on Friday. 61,464 shares of the company traded hands, compared to its average volume of 262,137. CNBX Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.05. The company has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01.

About CNBX Pharmaceuticals

(Get Free Report)

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.

Featured Articles

Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.